CRON - CIK 0001656472
Cronos Group Inc. trades as CRON and has a market capitalization of $1.03 B, making it the #2610 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $146.59M, up 24.6% from the prior year and net income of -$2.90M. This page tracks Cronos Group Inc. through 486 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 8 fiscal years Cronos Group Inc.'s revenue grew from $3.15M to $146.59M, a compound annual growth rate of 61.6%. Net profit margin expanded from -47.1% to -2.0% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-11 |
The largest companies sharing Cronos Group Inc.'s SEC industry classification (medicinal chemicals & botanical products).
Cronos Group Inc. (CRON) has a market capitalization of $1.03 B as of 2026-06-10, ranking #2610 among US-listed companies.
Cronos Group Inc. reported revenue of $146.59M for fiscal year 2025, an increase of 24.6% year over year.
In its latest fiscal year Cronos Group Inc. reported a net loss of $2.90M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.